Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Retained Earnings: 2016-2024

Historic Retained Earnings for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$40.1 million.

  • Organogenesis Holdings' Retained Earnings rose 2.10% to -$46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 2.10%. This contributed to the annual value of -$40.1 million for FY2024, which is 2.10% up from last year.
  • As of FY2024, Organogenesis Holdings' Retained Earnings stood at -$40.1 million, which was up 2.10% from -$41.0 million recorded in FY2023.
  • Organogenesis Holdings' Retained Earnings' 5-year high stood at -$40.1 million during FY2024, with a 5-year trough of -$155.0 million in FY2020.
  • In the last 3 years, Organogenesis Holdings' Retained Earnings had a median value of -$41.0 million in 2023 and averaged -$42.1 million.
  • Data for Organogenesis Holdings' Retained Earnings shows a peak YoY surged of 60.76% (in 2021) over the last 5 years.
  • Over the past 5 years, Organogenesis Holdings' Retained Earnings (Yearly) stood at -$155.0 million in 2020, then soared by 60.76% to -$60.8 million in 2021, then increased by 25.53% to -$45.3 million in 2022, then increased by 9.56% to -$41.0 million in 2023, then increased by 2.10% to -$40.1 million in 2024.